Long-term efficacy and safety of paliperidone palmitate once-monthly in Chinese patients with recent-onset schizophrenia

Background: The subgroup analysis of a primary study (NCT01051531) evaluated the effect of long-term paliperidone palmitate once-monthly (PP1M) therapy in Chinese patients with recent-onset schizophrenia responding unsatisfactorily to previous oral antipsychotics. Patients and methods: This 18-month...

Descripción completa

Detalles Bibliográficos
Autores principales: Si, Tianmei, Zhuo, Jianmin, Feng, Yu, Lu, Huafei, Hong, Di, Zhang, Lili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603286/
https://www.ncbi.nlm.nih.gov/pubmed/31303756
http://dx.doi.org/10.2147/NDT.S191803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603286/
https://www.ncbi.nlm.nih.gov/pubmed/31303756
http://dx.doi.org/10.2147/NDT.S191803

Ejemplares similares